Andrea Alimonti
http://usi.to/yad
Progetti
In corso (6)
- Alimonti A. (2024) Development of a drug discovery platform to identify microbiome-derived therapeutics
- Alimonti A. (2023) Microbiota regulation of prostate cancer growth and metastatic dissemination
- Alimonti A. (2022) Development of a senolytic of natural origin for antiaging therapy
- Alimonti A. (2022) Optimisation of therapies targeting the gut microbiota in prostate cancer
- Alimonti A., Barile L., Cippà P. (2021) Targeting cellular senescence in physiological, pathological and iatrogenic conditions
- Alimonti A. (2021) Excellence Grant –Development of senolytic therapies for chemotherapy-treated prostate cancer
Conclusi (7)
- Alimonti A. (2023) New frontiers in biological and environmental determinants of aging
- Alimonti A. (2020) Development of a senolytic of natural origin for anti-aging therapy
- Alimonti A., Calcinotto A., Catapano C., Iezzi G., Rossi D. (2019) High parameter cell analysis by BD FACSymphony
- Alimonti A. (2018) Development of senolytic therapies for chemotherapy-treated prostate cancer
- Alimonti A. (2016) Immune-senescence - Dual targeting of senescence and tumor immunity for cancer therapy
- Alimonti A. (2012) Manipulation of senescence pathways for cancer therapy: from experimental models to clinic
- Alimonti A. (2011) Manipulation of senescence pathways for cancer therapy: from experimental models to clinic
